The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a significant weight. In recent months, it’s become desirable among those who ...

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

Amy Schumer got candid about her experience with perimenopause and said that now that she is taking progesterone and estrogen, her symptoms have greatly improved. She also said the weight-loss drug ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

US poison control centers provided help for over 2 million human poison exposures. While infants and children account for ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

While anecdotal evidence suggests those taking the type 2 diabetes drug with a side effect of weight loss may lead to hair ...

Global Partners LP (NYSE:GLP) reported a revenue of $4.19 billion in Q4 of 2024, missing estimates by $1.62 billion. EPS was ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.